CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million CALGARY, AB, Dec. 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --  CannaPharmaRx, Inc. (OTC PINK:CPMD)(the “Company”), an emerging leader in development and operation of ultramodern, highly...

CannaPharmaRx Announces the Acquisition of a Minority Interest in GN Ventures, a Canadian Cannabis Producer, and the Appointment of Dominic Colvin as CEO and Chairman of the Board IRVINE, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- CannaPharmaRx, Inc. (OTC Pink Sheets: “CPMD”) announced today it has completed the acquisition of a minority interest in GN Ventures, LTD., (“GNC”),...